Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to EC-MPS in SPK Transplant Recipients
NCT00267150Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mycophenolate sodium in kidney transplantation and pancreas transplantation, sponsored by Novartis. Primary endpoints: Gastrointestinal Symptom Rating Scale total score and Health-related Quality of Life. Started Nov 2005; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplantationpancreas transplantation
Beyond the preview
Go deeper on NCT00267150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267150.